Assured Pharmacy – APHY – Stock Guru Profile
CHRONIC PAIN – Undeserved Expanding Market
Chronic Pain is pervasive in our society and unfortunately represents a growth industry.
Morphine continues to be the Army’s most commonly used painkilling drug. In Newsweek’s recent cover story on Chronic Pain Lt. Col. Chester (Trip) Buckenmaier, an anesthesiologist at Walter Reed Army Medical Center, noted that more than 90 percent of wounded soldiers have made it off the battlefield—the highest survival rate in American history—only to overwhelm chronic-pain clinics when they come home. He stated, “We’re seeing the tip of a tidal wave of pain.”
Robert DelVecchio, CEO of Assured Pharmacy, recognized this market years ago and understood that while the chronic pain market was growing exponentially, pharmacies willing to service chronic pain suffers were decreasing their services in that area and were wholly unable to address the additional documentation narcotic medications require and participate in the rigorous scrutiny required to determine the prescription’s validity.
In speaking with Stock Guru, Robert DelVecchio addressed the broad range of chronic pain ‘victims.’ “This is a demographic that is ever expanding. From baby boomers who have a lifetime of accumulated wear and tear to on the job injuries which are virtually ubiquitous in our society, they are everywhere and just under the radar. I think the Newsweek Cover Story on Chronic Pain has done an excellent job of bringing these issues and these patients to the forefront of our culture’s understanding of the deep problems in treatment and prescription issues associated with chronic pain. Its pervasiveness in our society is at an all time high.”
The Newsweek Cover Story on Chronic Pain noted:
Scientists don’t know why some people develop chronic problems after injuries while others continue on with no pain. It is nearly impossible to answer the question on a wide scale; pain simply has too many causes. Some patients fully recover from massive trauma. Others, like most of the boomers with aching backs and knees, find themselves debilitated by nothing more than the accumulated, mundane strains put on joints, bones and muscles every day. Even soldiers can fall into this second category—if the bullets don’t get them, the back pain brought on by months of jumping out of trucks, burdened with heavy equipment, well may.
As chronic pain sufferers surface in society and increase in numbers, Assured Pharmacy intends to become a household name and rollup the chronic pain pharmacy business across the United States. They are well on their way with pharmacies in the following cities:
- Kirkland, Washington
- Santa Ana, California
- Riverside, California
- Portland, Oregon
Assured Pharmacy’s business model and proven management with increasing sales and expanding locations has no impediments and only opportunities.
This company DOES NOT compete with Wal-Mart! This company fills a void in patient and physician pharmacy needs! Their success is reflected in expanding sales!
Source: APHY
Assured Pharmacy
17935 Sky Park Circle, Ste. F
Irvine, CA 92614
Phone: (949) 222-9971
Fax: (949) 222-0978
Investor Relations:
Andrew Brown
ROI Group LLC
212-495-0202
abrown@roiny.com
About Assured Pharmacy: Assured Pharmacy provides customized services for patients with and physicians treating chronic pain, including specialized expertise in dispensing pain medication, including Class II substances, streamlined prescription processes, digital prescribing technologies, and specialty drug compounding services. APHY also offers a complete line of durable medical equipment through its DME division. APHY currently operates retail sites in Portland, Oregon (three), Santa Ana and Riverside, California, and Kirkland, Washington. More information about APHY is available at http://www.assuredpharmacy.com.
Forward Looking Statements: Certain statements in this news release may constitute “forward-looking” statements within the meaning of section 21E of the Securities and Exchange Act of 1934. The Company believes that its expectations, as expressed in these statements are based on reasonable assumptions regarding the risks and uncertainties inherent in achieving those expectations. These statements are not, however, guarantees of future performance and actual results may differ materially. Some of the factors that may affect the forward looking statements in this news release are the availability of licensed personnel to operate pharmacies, the availability of suitable pharmacy locations, and the acceptance of new technologies by the medical profession. Other risk factors are listed in the most recent Annual Report on Form 10-KSB, Quarterly Report on Form 10-QSB, and most recent Registration Statement on Form SB-2 filed with the Securities and Exchange Commission. Such forward-looking statements involve risks, uncertainties, which may cause the actual results, performance, or achievement expressed or implied to differ.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com.
Disclosure: Pentony Enterprises LLC has been compensated $10,000 directly from the company for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.